Cigna Corporation

(New York Stock Exchange)
Back to all articles
Bullish +65

Cigna Group $CI Shares Sold by California Public Employees Retirement ...

AI-generated analysis

πŸ“‰ CalPERS trimmed its Cigna Group holdings by 7.6% in Q1, selling 46,513 shares while retaining a stake worth $151.7 million.

πŸ“ˆ Multiple smaller institutional investors increased their stakes in Q4, including Cary Street Partners (+11.0%) and CYBER HORNET ETFs LLC (+5.3%).

πŸ’° CEO David Cordani sold 201,878 shares for $59.1 million under a pre-arranged trading plan, reducing his ownership by 85.46%.

πŸ“Š Cigna Group beat Q1 earnings estimates with $7.79 EPS versus the consensus of $7.60 and revenue of $68.52 billion.

πŸš€ Revenue grew 4.6% year-over-year to $68.52 billion, exceeding analyst expectations of $66.29 billion.

πŸ’΅ The company paid a quarterly dividend of $1.56 per share, resulting in an annualized yield of 2.2%.

πŸ“ˆ Sanford C. Bernstein raised its price target to $381 and maintained an 'outperform' rating following the earnings report.

πŸ† The stock achieved a consensus rating of 'Moderate Buy' with a collective analyst price target of $338.80.

πŸ“‰ Corporate insider ownership dropped to 0.60% following significant sales by the CEO and Chief Accounting Officer.

Bullish Signals
  • Cigna Group reported Q1 earnings of $7.79 per share, beating analyst consensus estimates of $7.60 by $0.19.
  • Revenue reached $68.52 billion in the quarter, surpassing the expected $66.29 billion and growing 4.6% year-over-year.
  • The company demonstrated strong profitability with a net margin of 2.26% and a return on equity of 19.75%.
  • Sanford C. Bernstein increased its price target to $381.00 and reaffirmed an 'outperform' rating on the stock.
  • Guggenheim raised its price objective to $338.00 and maintained a 'buy' rating for Cigna Group shares.
  • Cantor Fitzgerald lifted its price target to $340.00 with an 'overweight' rating following recent performance.
  • Wells Fargo & Company boosted its price target to $305.00 while maintaining an 'equal weight' rating.
  • The company successfully paid a quarterly dividend of $1.56 per share, indicating healthy cash flow distribution.
Risk Factors
  • CEO David Cordani significantly reduced his personal stock ownership by selling over 200,000 shares for approximately $59 million.
  • Chief Accounting Officer Jamie G. Kates sold nearly 900 shares, decreasing his personal stake by 27.5%.
Full Analysis
California Public Employees Retirement System (CalPERS) reduced its stake in Cigna Group by 7.6% in the first quarter, selling 46,513 shares and holding approximately 0.22% of the company worth $151.7 million. While CalPERS exited a significant portion of its position, several smaller institutional investors and hedge funds increased their holdings during the fourth quarter, including Cary Street Partners, OLD National Bancorp, IHT Wealth Management, Whetstone Capital Advisors, and CYBER HORNET ETFs LLC. Corporate insiders executed notable stock sales recently. Chief Accounting Officer Jamie G. Kates sold 899 shares for approximately $268,450, reducing his personal stake by 27.5%. More significantly, CEO David Cordani sold 201,878 shares for roughly $59.1 million under a pre-arranged Rule 10b5-1 trading plan, leaving him with an ownership of 34,337 shares representing an 85.46% decrease from his previous position. Cigna Group reported strong quarterly financial results ending April 30th, beating analyst expectations for both earnings per share and revenue. The company posted $7.79 EPS against a consensus of $7.60 and generated $68.52 billion in revenue versus an estimated $66.29 billion. Revenue grew 4.6% year-over-year, with net margins at 2.26% and a return on equity of 19.75%. The company also paid a quarterly dividend of $1.56 per share to stockholders of record on June 4th. Analyst sentiment remains generally positive following the earnings beat and strong financial performance. Sanford C. Bernstein raised its price target to $381 with an 'outperform' rating, while Guggenheim, Cantor Fitzgerald, and Wells Fargo also increased their price targets or maintained buy ratings. The consensus price target stands at $338.80, reflecting confidence in the company's growth trajectory and operational efficiency.